A study of cellular migration on collagen has shown that the drug casticin reduces human melanoma cell migration by downregulating the EGFR/Ras/ERK pathway, NF-κB and the matrix metalloproteinases, MMP-1 and -2, which promote cancer invasion by enzymatically degrading collagen in the basement membrane [108]. This evidence concerns the gene NFKB1 and cancer.